Nasoferm (Xylometazoline Hydrochloride)

Xylometazoline Hydrochloride, the active ingredient in Nasoferm, is an imidazoline nasal decongestant presented as a nasal spray for nasal use. It relieves nasal congestion associated with the common cold, sinusitis and allergic rhinitis in adults and children.

GNH USA supplies Nasoferm as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Xylometazoline acts locally on the nasal mucosa to reduce swelling and improve airflow in several common conditions.

Common cold nasal congestion: reduces swelling and improves breathing during viral upper‑respiratory infections. Sinusitis‑related congestion: alleviates blockage of nasal passages caused by sinus inflammation. Allergic rhinitis: decreases nasal obstruction associated with allergic inflammation.

Nasoferm may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nasal irritation or burning sensation - Dryness of the nasal mucosa - Sneezing - Altered taste or bitter taste - Mild headache - Transient epistaxis (nosebleed)

Serious or Rare Side Effects: - Severe hypertension or hypertensive crisis - Tachycardia or arrhythmia - Rebound nasal congestion (rhinitis medicamentosa) after prolonged use - Allergic reactions such as rash, itching, swelling, or difficulty breathing - Nasal ulceration or perforation - Cardiovascular events in susceptible individuals

Before using Nasoferm, consider the following safety measures.

Age limitation: not recommended for children under 6 years unless advised by a healthcare professional. Duration of use: limit to 3‑5 days to avoid rebound congestion. Pregnancy: consult a healthcare professional as safety has not been established. Existing cardiovascular disease: use with caution due to possible systemic absorption. Concurrent nasal sprays: avoid using other vasoconstrictive nasal products simultaneously. Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Nasoferm can interact with other medications that affect blood pressure or sympathetic activity.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis. - Other nasal decongestants: additive vasoconstriction may cause excessive hypertension. - Systemic sympathomimetics (e.g., pseudoephedrine): increased cardiovascular effects.

Moderate Interactions (Monitor Closely): - Antihypertensive drugs: may reduce their efficacy. - Beta‑blockers: may mask tachycardia symptoms. - Tricyclic antidepressants: possible increase in side‑effect intensity.